People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clinipace Inc | — | Other Health Care | Series B | $122.3M | $85.9M | 2017 |
| Arbovax, Inc. | — | Biotechnology | Seed | $3.4M | $75.3M | 2010 |
Jeremy Mario at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeremy Mario on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Williams | 1 | 13 |
| Brian Carney | 1 | 10 |
| David Fitzgerald | 1 | 7 |
| Melissa Daniels | 1 | 6 |
| Steve Skolsky | 1 | 4 |
| Brian K. Carney | 1 | 2 |
| Steven List | 1 | 2 |
| Jonathan Lawrie | 1 | 2 |
| Jeff L. Williams | 1 | 2 |
| Chris Semple | 1 | 2 |
| Jesse Watson | 1 | 2 |
| Jeremy K Mario | 1 | 2 |
| Malcolm Thomas | 1 | 2 |
| Gena Reed | 1 | 1 |
| Ken Lee | 1 | 1 |
| Herb Hugill | 1 | 1 |
| Leslie Alexandre | 1 | 1 |
| Charlton Owensby | 1 | 1 |
| Christopher English | 1 | 1 |
| Troy Knauss | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.